InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.00%
)
US TECH 100
19,210.80
(
-0.02%
)
Dow Jones
39,127.80
(
0.00%
)
Brent Oil
85.35
(
1.04%
)
Bitcoin
61,550.54
(
1.21%
)
Post# of 462595
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Kmadd

Send PM Follow Ignore
Followers 7
Posts 379
Boards Moderated 0
Alias Born 12/11/2016

Kmadd

Re: falconer66a post# 361476

Friday, 05/27/2022 8:23:25 AM

Friday, May 27, 2022 8:23:25 AM

Post# of 462595
In Pharma trials, is it possible to submit a NDA based on secondary endpoint being successful? Sleep in all of these trials has always been a secondary endpoint, so I'm just wondering based on the hundreds of trial patient's data, in different treatment disorders, would Anavex be able to combine sleep therapy as an NDA?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!